Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
Background: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant, anticoagulant and fibrinolytic pathways, and modulate inflammation such as acute or chronic inflammatory state. These compo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Biomedical and Biotechnology Research Journal |
Subjects: | |
Online Access: | http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=81;epage=85;aulast=Gupta |
_version_ | 1811239244661784576 |
---|---|
author | Gajendra Kumar Gupta Purnima Dey Sarkar Rohit Manyal Mithun Singh Rajput |
author_facet | Gajendra Kumar Gupta Purnima Dey Sarkar Rohit Manyal Mithun Singh Rajput |
author_sort | Gajendra Kumar Gupta |
collection | DOAJ |
description | Background: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant, anticoagulant and fibrinolytic pathways, and modulate inflammation such as acute or chronic inflammatory state. These components may alter based on race, regions, or environment. Assessment of the hemostatic parameters in our region is imperative because the altered components so involved may give an insight as to the clinical phenotypes of Arab-Indian haplotypes we have in our setting. The objective of present study is to assess basic hemostatic and inflammatory parameters in patients with SCD during steady state at a tertiary care hospital. Methods: Blood samples of 95 patients with SCD during steady state attending M. Y. Hospital, Indore, India, during the period of November 2019 to March 2020 were screened for C-reactive protein (CRP) levels and platelet counts using latex enhanced immune-turbidimetric assay and hemotology analyzer, respectively, while prothrombin time (PT) and activated partial thromboplastin time (APTT) by automated coagulation analyzer. Results: It was observed that there is no significant difference among the mean platelet count (321.9 ± 97.63 × 109/l) of SCD patients and control groups (P = 0.69). CRP levels (6.60 ± 2.83 mg/l) were found to be significantly increased (P < 0.01) in SCD patients in comparison with their respective control. The mean PT (15.21 ± 1.58 s) and APTT values (37.69 ± 2.50 s) were found to be significantly increased (P < 0.05 for both) in SCD patient group when compared with control group. Conclusion: The study confirms that patients with SCD in steady state have significant prolonged coagulation indices. These can be an evidence of hypercoagulable state in SCD and may provide reference values appropriate for therapeutic target. We recommend that patients of SCD especially those with severe vaso-occlusive crises should have these hemostatic parameters as a basic test and during routine clinic follow-up for improved management. |
first_indexed | 2024-04-12T12:57:29Z |
format | Article |
id | doaj.art-f9128f730caa4f41b449eb59de8acc92 |
institution | Directory Open Access Journal |
issn | 2588-9834 2588-9842 |
language | English |
last_indexed | 2024-04-12T12:57:29Z |
publishDate | 2022-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Biomedical and Biotechnology Research Journal |
spelling | doaj.art-f9128f730caa4f41b449eb59de8acc922022-12-22T03:32:18ZengWolters Kluwer Medknow PublicationsBiomedical and Biotechnology Research Journal2588-98342588-98422022-01-0161818510.4103/bbrj.bbrj_162_21Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, IndiaGajendra Kumar GuptaPurnima Dey SarkarRohit ManyalMithun Singh RajputBackground: The evidence from various studies showed that patients with sickle cell disease (SCD) have altered components of hemostasis such as platelet function, procoagulant, anticoagulant and fibrinolytic pathways, and modulate inflammation such as acute or chronic inflammatory state. These components may alter based on race, regions, or environment. Assessment of the hemostatic parameters in our region is imperative because the altered components so involved may give an insight as to the clinical phenotypes of Arab-Indian haplotypes we have in our setting. The objective of present study is to assess basic hemostatic and inflammatory parameters in patients with SCD during steady state at a tertiary care hospital. Methods: Blood samples of 95 patients with SCD during steady state attending M. Y. Hospital, Indore, India, during the period of November 2019 to March 2020 were screened for C-reactive protein (CRP) levels and platelet counts using latex enhanced immune-turbidimetric assay and hemotology analyzer, respectively, while prothrombin time (PT) and activated partial thromboplastin time (APTT) by automated coagulation analyzer. Results: It was observed that there is no significant difference among the mean platelet count (321.9 ± 97.63 × 109/l) of SCD patients and control groups (P = 0.69). CRP levels (6.60 ± 2.83 mg/l) were found to be significantly increased (P < 0.01) in SCD patients in comparison with their respective control. The mean PT (15.21 ± 1.58 s) and APTT values (37.69 ± 2.50 s) were found to be significantly increased (P < 0.05 for both) in SCD patient group when compared with control group. Conclusion: The study confirms that patients with SCD in steady state have significant prolonged coagulation indices. These can be an evidence of hypercoagulable state in SCD and may provide reference values appropriate for therapeutic target. We recommend that patients of SCD especially those with severe vaso-occlusive crises should have these hemostatic parameters as a basic test and during routine clinic follow-up for improved management.http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=81;epage=85;aulast=Guptaactivated partial thromboplastin timec-reactive proteinplateletprothrombin timesickle cell disease |
spellingShingle | Gajendra Kumar Gupta Purnima Dey Sarkar Rohit Manyal Mithun Singh Rajput Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India Biomedical and Biotechnology Research Journal activated partial thromboplastin time c-reactive protein platelet prothrombin time sickle cell disease |
title | Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India |
title_full | Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India |
title_fullStr | Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India |
title_full_unstemmed | Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India |
title_short | Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India |
title_sort | sickle cell disease assessment of hemostasis parameters in steady state patients at tertiary care hospital indore india |
topic | activated partial thromboplastin time c-reactive protein platelet prothrombin time sickle cell disease |
url | http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=1;spage=81;epage=85;aulast=Gupta |
work_keys_str_mv | AT gajendrakumargupta sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia AT purnimadeysarkar sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia AT rohitmanyal sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia AT mithunsinghrajput sicklecelldiseaseassessmentofhemostasisparametersinsteadystatepatientsattertiarycarehospitalindoreindia |